All Stories

  1. Pharmacokinetics and pharmacodynamics of high-dose isoniazid for the treatment of rifampicin- or multidrug-resistant tuberculosis in Indonesia

    Article • Journal of Antimicrobial Chemotherapy, March 2024, Oxford University Press (OUP)

    Fajri Gafar

  2. TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine

    Article • The International Journal of Tuberculosis and Lung Disease, November 2023, International Union Against Tuberculosis and Lung Disease

    Fajri Gafar, ioana MUNTEANU

  3. Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?

    Article • The International Journal of Tuberculosis and Lung Disease, May 2023, International Union Against Tuberculosis and Lung Disease

    Fajri Gafar

  4. Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis

    Article • European Respiratory Journal, November 2022, European Respiratory Society (ERS)

    Fajri Gafar

  5. Treatment Outcomes of Childhood Tuberculous Meningitis in a Real-World Retrospective Cohort, Bandung, Indonesia

    Article • Emerging Infectious Diseases, March 2022, Centers for Disease Control and Prevention (CDC)

    Fajri Gafar

  6. Optimizing Antimicrobial and Host-Directed Therapies to Improve Clinical Outcomes of Childhood Tuberculous Meningitis

    Article • Clinical Infectious Diseases, December 2021, Oxford University Press (OUP)

    Fajri Gafar

  7. Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis

    Article • Archives of Disease in Childhood, June 2021, BMJ

    Fajri Gafar

  8. Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review

    Article • The International Journal of Tuberculosis and Lung Disease, August 2020, International Union Against Tuberculosis and Lung Disease

    Fajri Gafar

  9. Towards elimination of childhood and adolescent tuberculosis in the Netherlands: an epidemiological time-series analysis of national surveillance data

    Article • European Respiratory Journal, May 2020, European Respiratory Society (ERS)

    Fajri Gafar

  10. Nationwide analysis of treatment outcomes in children and adolescents routinely treated for tuberculosis in The Netherlands

    Article • European Respiratory Journal, September 2019, European Respiratory Society (ERS)

    Fajri Gafar

  11. Antituberculosis Drug-induced Liver Injury in Children

    Article • The Pediatric Infectious Disease Journal, January 2019, Wolters Kluwer Health

    Fajri Gafar

  12. Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma

    Article • December 2018, Springer Science + Business Media

    Fajri Gafar